Fat as an endocrine organ: relationship to the metabolic syndrome.

scientific article

Fat as an endocrine organ: relationship to the metabolic syndrome. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1097/00000441-200512000-00005
P698PubMed publication ID16355012

P2093author name stringJohannes B Prins
Louise Hutley
P2860cites workRETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulinQ34377294
Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in ratsQ46466725
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectmetabolic syndromeQ657193
P304page(s)280-289
P577publication date2005-12-01
P1433published inAmerican Journal of the Medical SciencesQ7713509
P1476titleFat as an endocrine organ: relationship to the metabolic syndrome.
P478volume330

Reverse relations

cites work (P2860)
Q21284500A comprehensive review on metabolic syndrome
Q36131145A discrete Single Delay Model for the Intra-Venous Glucose Tolerance Test
Q53210315A large volume of visceral adipose tissue leads to severe acute pancreatitis.
Q38998402AMPK/Mitochondria in Metabolic Diseases
Q35890340Abdominal Obesity and Insulin Resistance in People Exposed to Moderate-to-High Levels of Dioxin
Q47430165Abdominal wall fat index in neonates: correlation with birth size
Q43257951Acute stress and food-related reward activation in the brain during food choice during eating in the absence of hunger
Q51040934Adipokines induce catabolism of newly synthesized matrix in cartilage and meniscus tissues.
Q37311261Adiponectin multimers in maternal plasma.
Q89587263Adipose Tumor Microenvironment
Q33993047Aging per se increases the susceptibility to free fatty acid-induced insulin resistance
Q36800296An RBP4 promoter polymorphism increases risk of type 2 diabetes
Q36252804Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism
Q33714639Body mass index is associated with region-dependent metabolic reprogramming of adipose tissue.
Q84326004C-reactive protein and atrial fibrillation in idiopathic dilated cardiomyopathy
Q37624585CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).
Q42770007Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitis
Q35015210Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods
Q35861003Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue
Q33270433Characterization of the human visceral adipose tissue secretome
Q24320019Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism
Q43750803Cholecystosteatosis: an explanation for increased cholecystectomy rates
Q42599624Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes
Q53044458Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery.
Q37511029Consequences of morbid obesity on the kidney. Where are we going?
Q37580907Contribution of insulin resistance to vascular dysfunction.
Q36966006Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents.
Q54417730Determinants of systolic blood pressure response during exercise in overweight subjects.
Q43054682Differential adipokine response in genetically predisposed lean and obese rats during inflammation: a role in modulating experimental colitis?
Q36328554Differential changes in vascular mRNA levels between rat iliac and renal arteries produced by cessation of voluntary running
Q42494445Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients
Q26824679Effects of intermittent fasting on metabolism in men
Q26801281Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
Q34484924Evaluation of a meal replacement-based weight management program in primary care settings according to the actual European Clinical Practice Guidelines for the Management of Obesity in Adults
Q43996232Evaluation of the association between retinal binding protein 4 polymorphisms and type 2 diabetes in Chinese by DHPLC.
Q35101658F3MB(PANDER) decreases mice hepatic triglyceride and is associated with decreased DGAT1 expression
Q28589295Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis
Q33437489Fat poetry: a kingdom for PPAR gamma
Q37395817Fatalism and cardio-metabolic dysfunction in Mexican-American women
Q35616553Genotype x adiposity interaction linkage analyses reveal a locus on chromosome 1 for lipoprotein-associated phospholipase A2, a marker of inflammation and oxidative stress
Q40625685Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity?
Q52948768Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion.
Q37709360Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review
Q36397896Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-D-glucose uptake in human adipocytes
Q45981882Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese.
Q55109720Individual and area-based indicators of acculturation and the metabolic syndrome among low-income Mexican American women living in a border region.
Q37024566Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome.
Q37544889Inflammatory disease processes and interactions with nutrition
Q42083478Intracellular infections enhance interleukin-6 and plasminogen activator inhibitor 1 production by cocultivated human adipocytes and THP-1 monocytes
Q28388335Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
Q36640581Is the metabolic syndrome a real clinical entity and should it receive drug treatment?
Q42255126Lack of adenovirus DNA in mediastinal adipose tissue of obese/overweight adults with cardiovascular disorders?
Q88637009Leptin is an independent marker of metabolic syndrome in elderly adults with type 2 diabetes
Q35551453Location, location, location: Beneficial effects of autologous fat transplantation
Q38855437Long-Term Weight-Loss Maintenance by a Meal Replacement Based Weight Management Program in Primary Care.
Q50635132Measurement and Interpretation of Body Mass Index During Childhood and Adolescence.
Q37597592Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction
Q36021359Meniscus is more susceptible than cartilage to catabolic and anti-anabolic effects of adipokines
Q35573741Metabolic syndrome in peritoneal dialysis patients
Q37358721Metabolic syndrome-From human organ disease to laminar failure in equids
Q37149405Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment
Q30414466Obesidomics: contribution of adipose tissue secretome analysis to obesity research
Q57823740Obesity and Pancreatic Cysts in African American Patients
Q36549038Obesity and its therapy: from genes to community action
Q34496907Obesity hypertension: the regulatory role of leptin
Q34891638Obesity, abdominal obesity, and insulin resistance
Q30397621Overfat and Underfat: New Terms and Definitions Long Overdue
Q36865845Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study
Q36763396Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C.
Q90352236Pharmacological and Toxicological Threshold of Bisammonium Tetrakis 4-(N,N-Dimethylamino)pyridinium Decavanadate in a Rat Model of Metabolic Syndrome and Insulin Resistance
Q36696378Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women.
Q33932584Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial
Q88687398Relationship Between Visceral Obesity and Postoperative Inflammatory Response Following Minimally Invasive Esophagectomy
Q61799509Relationships between Vitamin D₃ and Metabolic Syndrome
Q36699860Resistin: a hormone which induces insulin resistance is increased in normal pregnancy.
Q35944715Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits
Q89367239Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study
Q49987876Role of Body Mass Index in Acute Kidney Injury Patients after Cardiac Surgery
Q48513307Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women
Q80989655Supersized kidneys: Lessons from the preclinical obese kidney
Q54157218Swim training and the genetic expression of adipokines in monosodium glutamate-treated obese rats.
Q36635081The association of carotid intima media thickness with retinol binding protein-4 and total and high molecular weight adiponectin in type 2 diabetic patients
Q33652718The effects of the metabolic syndrome on coronary artery bypass grafting surgery
Q37915059The interaction of short-chain fatty acids with adipose tissue: relevance for prevention of type 2 diabetes
Q34364206The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC).
Q35013868The pathophysiology of obesity and its clinical manifestations
Q27003277The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance
Q37872237The role of obesity in kidney disease: recent findings and potential mechanisms
Q37363488Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines.
Q51805694Vagaries of adipose tissue innervation.
Q36419240Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight
Q35006811Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis
Q38907257What Do We Mean by Accumulation? Advancing Conceptual Precision for a Core Idea in Gerontology
Q94501996[Metabolic syndrome]
Q81241819[Pathogenesis of the metabolic syndrome]

Search more.